ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 75 filers reported holding ARCELLX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,201,776 | -71.2% | 61,365 | -74.7% | 0.00% | -75.0% |
Q2 2023 | $7,656,309 | +205604.2% | 242,135 | +100.4% | 0.00% | +100.0% |
Q1 2023 | $3,722 | +71.0% | 120,798 | +71.9% | 0.00% | +100.0% |
Q4 2022 | $2,177 | -99.5% | 70,277 | +230.9% | 0.00% | – |
Q3 2022 | $399,000 | -74.2% | 21,238 | -75.2% | 0.00% | -100.0% |
Q2 2022 | $1,546,000 | +20.9% | 85,501 | -6.3% | 0.00% | 0.0% |
Q1 2022 | $1,279,000 | – | 91,215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |